Xeris Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for XERIS, and when can generic versions of XERIS drugs launch?
XERIS has two approved drugs.
There is one US patent protecting XERIS drugs.
There are eighteen patent family members on XERIS drugs in thirteen countries.
Summary for Xeris
| International Patents: | 18 |
| US Patents: | 1 |
| Tradenames: | 4 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Xeris
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xeris | GVOKE PFS | glucagon | SOLUTION;SUBCUTANEOUS | 212097-002 | Sep 10, 2019 | RX | Yes | Yes | 9,649,364 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Xeris | GVOKE HYPOPEN | glucagon | SOLUTION;SUBCUTANEOUS | 212097-004 | Sep 10, 2019 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | |||||
| Xeris | GVOKE HYPOPEN | glucagon | SOLUTION;SUBCUTANEOUS | 212097-004 | Sep 10, 2019 | RX | Yes | Yes | 9,649,364 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Xeris | GVOKE HYPOPEN | glucagon | SOLUTION;SUBCUTANEOUS | 212097-003 | Sep 10, 2019 | RX | Yes | Yes | 9,649,364 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Xeris | DARANIDE | dichlorphenamide | TABLET;ORAL | 011366-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | |||||
| Xeris | GVOKE PFS | glucagon | SOLUTION;SUBCUTANEOUS | 212097-001 | Sep 10, 2019 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Xeris Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 3307295 | See Plans and Pricing |
| World Intellectual Property Organization (WIPO) | 2017053922 | See Plans and Pricing |
| Mexico | 2018003705 | See Plans and Pricing |
| South Africa | 201801912 | See Plans and Pricing |
| Japan | 6835831 | See Plans and Pricing |
| Canada | 2999404 | See Plans and Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
